Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$53.58 - $57.02 $276,847 - $294,622
5,167 New
5,167 $290,000
Q2 2021

Aug 11, 2021

SELL
$100.34 - $115.69 $93,316 - $107,591
-930 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$85.88 - $105.36 $46,117 - $56,578
-537 Reduced 36.61%
930 $97,000
Q3 2020

Nov 09, 2020

BUY
$72.74 - $92.5 $106,709 - $135,697
1,467 New
1,467 $125,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.